An integrated perspective for the diagnosis and therapy of neurodevelopmental disorders – From an engineering point of view
[Display omitted] Neurodevelopmental disorders (NDDs) are complex conditions with largely unknown pathophysiology. While many NDD symptoms are familiar, the cause of these disorders remains unclear and may involve a combination of genetic, biological, psychosocial, and environmental risk factors. Cu...
Gespeichert in:
Veröffentlicht in: | Advanced drug delivery reviews 2023-03, Vol.194, p.114723-114723, Article 114723 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 114723 |
---|---|
container_issue | |
container_start_page | 114723 |
container_title | Advanced drug delivery reviews |
container_volume | 194 |
creator | Mintz Hemed, Nofar Melosh, Nicholas A. |
description | [Display omitted]
Neurodevelopmental disorders (NDDs) are complex conditions with largely unknown pathophysiology. While many NDD symptoms are familiar, the cause of these disorders remains unclear and may involve a combination of genetic, biological, psychosocial, and environmental risk factors. Current diagnosis relies heavily on behaviorally defined criteria, which may be biased by the clinical team’s professional and cultural expectations, thus a push for new biological-based biomarkers for NDDs diagnosis is underway. Emerging new research technologies offer an unprecedented view into the electrical, chemical, and physiological activity in the brain and with further development in humans may provide clinically relevant diagnoses. These could also be extended to new treatment options, which can start to address the underlying physiological issues. When combined with current speech, language, occupational therapy, and pharmacological treatment these could greatly improve patient outcomes. The current review will discuss the latest technologies that are being used or may be used for NDDs diagnosis and treatment. The aim is to provide an inspiring and forward-looking view for future research in the field. |
doi_str_mv | 10.1016/j.addr.2023.114723 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2774267340</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0169409X23000388</els_id><sourcerecordid>2774267340</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-6f9f0858c7cd3038de062f3b448599582181a449ea2540a1227334e3591a8b043</originalsourceid><addsrcrecordid>eNp9kM1q3DAURkVoyEynfYEugpbd2NWfLRmyCSFpC4FsEshOaKzrqQZbciTPhCwCfYe8YZ6kMpNmmdWFy_m-yz0IfaOkpITWP7alsTaWjDBeUiok40doSZVkhWKN-ISWGWoKQZr7Bfqc0pYQymRNTtCC11LURMolej732PkJNtFMYPEIMY3QTm4PuAsRT38AW2c2PiSXsPF23kQzPuHQYQ-7GCzsoQ_jAH4yfWZTiDaX4Ne_L_gqhiGHMPiN8wDR-Q0eQz43p_cOHr-g4870Cb6-zRW6u7q8vfhVXN_8_H1xfl20vKqnou6ajqhKtbK1nHBlgdSs42shVNU0lWJUUSNEA4ZVghjKmORcAK8aatSaCL5C3w-9YwwPO0iTHlxqoe-Nh7BLmkkpWC25IBllB7SNIaUInR6jG0x80pToWbve6lm7nrXrg_YcOn3r360HsO-R_54zcHYAIH-ZP486tQ58C9bFrFvb4D7q_wcl25Ub</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2774267340</pqid></control><display><type>article</type><title>An integrated perspective for the diagnosis and therapy of neurodevelopmental disorders – From an engineering point of view</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Mintz Hemed, Nofar ; Melosh, Nicholas A.</creator><creatorcontrib>Mintz Hemed, Nofar ; Melosh, Nicholas A.</creatorcontrib><description>[Display omitted]
Neurodevelopmental disorders (NDDs) are complex conditions with largely unknown pathophysiology. While many NDD symptoms are familiar, the cause of these disorders remains unclear and may involve a combination of genetic, biological, psychosocial, and environmental risk factors. Current diagnosis relies heavily on behaviorally defined criteria, which may be biased by the clinical team’s professional and cultural expectations, thus a push for new biological-based biomarkers for NDDs diagnosis is underway. Emerging new research technologies offer an unprecedented view into the electrical, chemical, and physiological activity in the brain and with further development in humans may provide clinically relevant diagnoses. These could also be extended to new treatment options, which can start to address the underlying physiological issues. When combined with current speech, language, occupational therapy, and pharmacological treatment these could greatly improve patient outcomes. The current review will discuss the latest technologies that are being used or may be used for NDDs diagnosis and treatment. The aim is to provide an inspiring and forward-looking view for future research in the field.</description><identifier>ISSN: 0169-409X</identifier><identifier>EISSN: 1872-8294</identifier><identifier>DOI: 10.1016/j.addr.2023.114723</identifier><identifier>PMID: 36746077</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Biomarkers ; Brain ; Humans ; Neurodevelopmental Disorders - genetics ; Neurodevelopmental Disorders - psychology</subject><ispartof>Advanced drug delivery reviews, 2023-03, Vol.194, p.114723-114723, Article 114723</ispartof><rights>2023 Elsevier B.V.</rights><rights>Copyright © 2023 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-6f9f0858c7cd3038de062f3b448599582181a449ea2540a1227334e3591a8b043</citedby><cites>FETCH-LOGICAL-c356t-6f9f0858c7cd3038de062f3b448599582181a449ea2540a1227334e3591a8b043</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.addr.2023.114723$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36746077$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mintz Hemed, Nofar</creatorcontrib><creatorcontrib>Melosh, Nicholas A.</creatorcontrib><title>An integrated perspective for the diagnosis and therapy of neurodevelopmental disorders – From an engineering point of view</title><title>Advanced drug delivery reviews</title><addtitle>Adv Drug Deliv Rev</addtitle><description>[Display omitted]
Neurodevelopmental disorders (NDDs) are complex conditions with largely unknown pathophysiology. While many NDD symptoms are familiar, the cause of these disorders remains unclear and may involve a combination of genetic, biological, psychosocial, and environmental risk factors. Current diagnosis relies heavily on behaviorally defined criteria, which may be biased by the clinical team’s professional and cultural expectations, thus a push for new biological-based biomarkers for NDDs diagnosis is underway. Emerging new research technologies offer an unprecedented view into the electrical, chemical, and physiological activity in the brain and with further development in humans may provide clinically relevant diagnoses. These could also be extended to new treatment options, which can start to address the underlying physiological issues. When combined with current speech, language, occupational therapy, and pharmacological treatment these could greatly improve patient outcomes. The current review will discuss the latest technologies that are being used or may be used for NDDs diagnosis and treatment. The aim is to provide an inspiring and forward-looking view for future research in the field.</description><subject>Biomarkers</subject><subject>Brain</subject><subject>Humans</subject><subject>Neurodevelopmental Disorders - genetics</subject><subject>Neurodevelopmental Disorders - psychology</subject><issn>0169-409X</issn><issn>1872-8294</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kM1q3DAURkVoyEynfYEugpbd2NWfLRmyCSFpC4FsEshOaKzrqQZbciTPhCwCfYe8YZ6kMpNmmdWFy_m-yz0IfaOkpITWP7alsTaWjDBeUiok40doSZVkhWKN-ISWGWoKQZr7Bfqc0pYQymRNTtCC11LURMolej732PkJNtFMYPEIMY3QTm4PuAsRT38AW2c2PiSXsPF23kQzPuHQYQ-7GCzsoQ_jAH4yfWZTiDaX4Ne_L_gqhiGHMPiN8wDR-Q0eQz43p_cOHr-g4870Cb6-zRW6u7q8vfhVXN_8_H1xfl20vKqnou6ajqhKtbK1nHBlgdSs42shVNU0lWJUUSNEA4ZVghjKmORcAK8aatSaCL5C3w-9YwwPO0iTHlxqoe-Nh7BLmkkpWC25IBllB7SNIaUInR6jG0x80pToWbve6lm7nrXrg_YcOn3r360HsO-R_54zcHYAIH-ZP486tQ58C9bFrFvb4D7q_wcl25Ub</recordid><startdate>202303</startdate><enddate>202303</enddate><creator>Mintz Hemed, Nofar</creator><creator>Melosh, Nicholas A.</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202303</creationdate><title>An integrated perspective for the diagnosis and therapy of neurodevelopmental disorders – From an engineering point of view</title><author>Mintz Hemed, Nofar ; Melosh, Nicholas A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-6f9f0858c7cd3038de062f3b448599582181a449ea2540a1227334e3591a8b043</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Biomarkers</topic><topic>Brain</topic><topic>Humans</topic><topic>Neurodevelopmental Disorders - genetics</topic><topic>Neurodevelopmental Disorders - psychology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mintz Hemed, Nofar</creatorcontrib><creatorcontrib>Melosh, Nicholas A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Advanced drug delivery reviews</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mintz Hemed, Nofar</au><au>Melosh, Nicholas A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>An integrated perspective for the diagnosis and therapy of neurodevelopmental disorders – From an engineering point of view</atitle><jtitle>Advanced drug delivery reviews</jtitle><addtitle>Adv Drug Deliv Rev</addtitle><date>2023-03</date><risdate>2023</risdate><volume>194</volume><spage>114723</spage><epage>114723</epage><pages>114723-114723</pages><artnum>114723</artnum><issn>0169-409X</issn><eissn>1872-8294</eissn><abstract>[Display omitted]
Neurodevelopmental disorders (NDDs) are complex conditions with largely unknown pathophysiology. While many NDD symptoms are familiar, the cause of these disorders remains unclear and may involve a combination of genetic, biological, psychosocial, and environmental risk factors. Current diagnosis relies heavily on behaviorally defined criteria, which may be biased by the clinical team’s professional and cultural expectations, thus a push for new biological-based biomarkers for NDDs diagnosis is underway. Emerging new research technologies offer an unprecedented view into the electrical, chemical, and physiological activity in the brain and with further development in humans may provide clinically relevant diagnoses. These could also be extended to new treatment options, which can start to address the underlying physiological issues. When combined with current speech, language, occupational therapy, and pharmacological treatment these could greatly improve patient outcomes. The current review will discuss the latest technologies that are being used or may be used for NDDs diagnosis and treatment. The aim is to provide an inspiring and forward-looking view for future research in the field.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>36746077</pmid><doi>10.1016/j.addr.2023.114723</doi><tpages>1</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0169-409X |
ispartof | Advanced drug delivery reviews, 2023-03, Vol.194, p.114723-114723, Article 114723 |
issn | 0169-409X 1872-8294 |
language | eng |
recordid | cdi_proquest_miscellaneous_2774267340 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | Biomarkers Brain Humans Neurodevelopmental Disorders - genetics Neurodevelopmental Disorders - psychology |
title | An integrated perspective for the diagnosis and therapy of neurodevelopmental disorders – From an engineering point of view |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T01%3A48%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=An%20integrated%20perspective%20for%20the%20diagnosis%20and%20therapy%20of%20neurodevelopmental%20disorders%20%E2%80%93%20From%20an%20engineering%20point%20of%20view&rft.jtitle=Advanced%20drug%20delivery%20reviews&rft.au=Mintz%20Hemed,%20Nofar&rft.date=2023-03&rft.volume=194&rft.spage=114723&rft.epage=114723&rft.pages=114723-114723&rft.artnum=114723&rft.issn=0169-409X&rft.eissn=1872-8294&rft_id=info:doi/10.1016/j.addr.2023.114723&rft_dat=%3Cproquest_cross%3E2774267340%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2774267340&rft_id=info:pmid/36746077&rft_els_id=S0169409X23000388&rfr_iscdi=true |